Biophytis (BPTSY) Competitors $2.86 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends BPTSY vs. CPHI, ATXI, ARTL, APM, TCRT, DWTX, SNPX, ONCT, LIXT, and NBYShould you be buying Biophytis stock or one of its competitors? The main competitors of Biophytis include China Pharma (CPHI), Avenue Therapeutics (ATXI), Artelo Biosciences (ARTL), Aptorum Group (APM), Alaunos Therapeutics (TCRT), Dogwood Therapeutics (DWTX), Synaptogenix (SNPX), Oncternal Therapeutics (ONCT), Lixte Biotechnology (LIXT), and NovaBay Pharmaceuticals (NBY). These companies are all part of the "pharmaceutical preparations" industry. Biophytis vs. China Pharma Avenue Therapeutics Artelo Biosciences Aptorum Group Alaunos Therapeutics Dogwood Therapeutics Synaptogenix Oncternal Therapeutics Lixte Biotechnology NovaBay Pharmaceuticals China Pharma (NYSE:CPHI) and Biophytis (NASDAQ:BPTSY) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, community ranking, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability. Do institutionals & insiders have more ownership in CPHI or BPTSY? 0.1% of Biophytis shares are owned by institutional investors. 17.3% of China Pharma shares are owned by company insiders. Comparatively, 3.7% of Biophytis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community prefer CPHI or BPTSY? China Pharma and Biophytis both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformChina PharmaOutperform VotesNo VotesUnderperform Votes72100.00% BiophytisN/AN/A Does the media refer more to CPHI or BPTSY? In the previous week, China Pharma had 1 more articles in the media than Biophytis. MarketBeat recorded 1 mentions for China Pharma and 0 mentions for Biophytis. China Pharma's average media sentiment score of 0.38 beat Biophytis' score of 0.00 indicating that China Pharma is being referred to more favorably in the media. Company Overall Sentiment China Pharma Neutral Biophytis Neutral Is CPHI or BPTSY more profitable? Biophytis has a net margin of 0.00% compared to China Pharma's net margin of -85.56%. Biophytis' return on equity of 0.00% beat China Pharma's return on equity.Company Net Margins Return on Equity Return on Assets China Pharma-85.56% -63.93% -31.42% Biophytis N/A N/A N/A Which has preferable valuation & earnings, CPHI or BPTSY? China Pharma has higher revenue and earnings than Biophytis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina Pharma$7.01M0.55-$3.08MN/AN/ABiophytisN/AN/A-$18.43MN/AN/A Which has more volatility and risk, CPHI or BPTSY? China Pharma has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500. Comparatively, Biophytis has a beta of 1.15, indicating that its stock price is 15% more volatile than the S&P 500. SummaryChina Pharma and Biophytis tied by winning 5 of the 10 factors compared between the two stocks. Ad Darwin2024 Election Year Stocks: Uncover Hidden Gems!In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.Secure your copy now by clicking this link. Get Biophytis News Delivered to You Automatically Sign up to receive the latest news and ratings for BPTSY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BPTSY vs. The Competition Export to ExcelMetricBiophytisPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.00M$6.53B$5.10B$8.84BDividend YieldN/A8.11%5.04%4.07%P/E RatioN/A5.5095.1214.22Price / SalesN/A375.021,217.3088.42Price / CashN/A52.5939.4936.27Price / Book-0.1810.276.976.37Net Income-$18.43M$153.22M$118.73M$225.56M7 Day Performance-18.29%-1.19%-1.22%-0.02%1 Month Performance-16.37%-6.71%-3.07%2.04%1 Year PerformanceN/A32.39%32.52%28.00% Biophytis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BPTSYBiophytisN/A$2.86flatN/AN/A$1.00MN/A0.0022CPHIChina PharmaN/A$0.20+3.9%N/A-59.6%$3.84M$7.01M0.00231ATXIAvenue Therapeutics1.4277 of 5 stars$1.98-1.5%N/A-86.7%$3.78MN/A0.114Negative NewsGap DownARTLArtelo Biosciences3.2257 of 5 stars$1.14-0.9%$5.00+338.6%-8.7%$3.68MN/A0.005Analyst RevisionAPMAptorum Group0.3434 of 5 stars$0.71-3.5%N/A-54.6%$3.68M$430,000.000.0030Gap DownTCRTAlaunos TherapeuticsN/A$2.27+6.6%N/A-81.3%$3.63MN/A0.0040DWTXDogwood TherapeuticsN/A$2.73+12.3%N/AN/A$3.63MN/A-0.374Negative NewsGap DownHigh Trading VolumeSNPXSynaptogenix2.0975 of 5 stars$2.60-1.9%$14.00+438.5%-59.2%$3.54MN/A0.004Negative NewsONCTOncternal Therapeutics2.266 of 5 stars$1.19+4.4%$20.00+1,580.7%-83.1%$3.52M$790,000.000.0030Analyst ForecastLIXTLixte Biotechnology0.2965 of 5 stars$1.55+4.0%N/A-49.7%$3.49MN/A0.003Positive NewsNBYNovaBay Pharmaceuticals0.5204 of 5 stars$0.70-1.0%$0.85+21.2%-93.7%$3.45M$14.73M0.0030 Related Companies and Tools Related Companies China Pharma Alternatives Avenue Therapeutics Alternatives Artelo Biosciences Alternatives Aptorum Group Alternatives Alaunos Therapeutics Alternatives Dogwood Therapeutics Alternatives Synaptogenix Alternatives Oncternal Therapeutics Alternatives Lixte Biotechnology Alternatives NovaBay Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BPTSY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biophytis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biophytis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BPTSY Stock Alerts